Plasma anti-CD4 IgG is associated with brain abnormalities in people with HIV on antiretroviral therapy.
ART
Autoantibodies
Brain
CD4
CNS
Cognition
HIV
Journal
Journal of neurovirology
ISSN: 1538-2443
Titre abrégé: J Neurovirol
Pays: United States
ID NLM: 9508123
Informations de publication
Date de publication:
04 2021
04 2021
Historique:
received:
21
12
2020
accepted:
28
02
2021
revised:
29
01
2021
pubmed:
13
3
2021
medline:
15
12
2021
entrez:
12
3
2021
Statut:
ppublish
Résumé
Anti-CD4 IgG autoantibodies have been implicated in CD4
Identifiants
pubmed: 33710596
doi: 10.1007/s13365-021-00966-0
pii: 10.1007/s13365-021-00966-0
doi:
Substances chimiques
Anti-HIV Agents
0
Autoantibodies
0
Autoantigens
0
CD4 Antigens
0
Immunoglobulin G
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
334-339Subventions
Organisme : NIH HHS
ID : 1P20GM125526-01A1
Pays : United States
Références
Battegay M, Nüesch R, Hirschel B, Kaufmann GR (2006) Immunological recovery and antiretroviral therapy in HIV-1 infection. Lancet Infect Dis 6(5):280–287
doi: 10.1016/S1473-3099(06)70463-7
Bowley MP, Drevets WC, Ongur D, Price JL (2002) Low glial numbers in the amygdala in major depressive disorder. Biol Psychiatry 52(5):404–412
doi: 10.1016/S0006-3223(02)01404-X
Calcagno A, Romito A, Atzori C, Ghisetti V, Cardellino C, Audagnotto S, Scarvaglieri E, Lipani F, Imperiale D, Di Perri G, Bonora S (2016) Blood brain barrier impairment in HIV-positive naïve and effectively treated patients: immune activation versus astrocytosis. J Neuroimmune Pharmacol 12(1):187–193
doi: 10.1007/s11481-016-9717-2
Clark US, Sweet LH, Morgello S, Philip NS, Cohen RA (2017) High early life stress and aberrant amygdala activity: risk factors for elevated neuropsychiatric symptoms in HIV+ adults. Brain Imaging Behav 11(3):649–665
doi: 10.1007/s11682-016-9542-5
Diaz A, Alos L, Leon A, Mozos A, Caballero M, Martinez A, Plana M, Gallart T, Gil C, Leal M, Gatell JM, Garcia F (2010) H. I. V. i. Study Group of Lymphoid Tissue immunopathogenesis in. "Factors associated with collagen deposition in lymphoid tissue in long-term treated HIV-infected patients." AIDS 24(13):2029-2039
Drevets WC (2003) Neuroimaging abnormalities in the amygdala in mood disorders. Ann N Y Acad Sci 985:420–444
doi: 10.1111/j.1749-6632.2003.tb07098.x
Ellis RJ, Badiee J, Vaida F, Letendre S, Heaton RK, Clifford D, Collier A.C, Gelman B, McArthur J, Morgello S, McCutchan JA, Grant I, Group C (2011) "CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy." AIDS 25(14):1747-1751
Gannon P, Khan MZ, Kolson DL (2011) Current understanding of HIV-associated neurocognitive disorders pathogenesis. Curr Opin Neurol 24(3):275–283
doi: 10.1097/WCO.0b013e32834695fb
Garcia F, de Lazzari E, Plana M, Castro P, Mestre G, Nomdedeu M, Fumero E, Martinez E, Mallolas J, Blanco JL, Miro JM, Pumarola T, Gallart T, Gatell JM (2004) Long-term CD4+ T-cell response to highly active antiretroviral therapy according to baseline CD4+ T-cell count. J Acquir Immune Defic Syndr 36(2):702–713
doi: 10.1097/00126334-200406010-00007
Gillies MJ, Hyam JA, Weiss AR, Antoniades CA, Bogacz R, Fitzgerald JJ, Aziz TZ, Whittington MA, Green AL (2017) The cognitive role of the globus pallidus interna: insights from disease states. Exp Brain Res 235(5):1455–1465
doi: 10.1007/s00221-017-4905-8
Gutierrez F, Padilla S, Masia M, Iribarren JA, Moreno S, Viciana P, Munoz L, Gomez Sirvent JL, Vidal F, Lopez-Aldeguer J, Blanco JR, Leal M, Rodriguez-Arenas MA, Perez Hoyos S, Co RM (2006) Clinical outcome of HIV-infected patients with sustained virologic response to antiretroviral therapy: long-term follow-up of a multicenter cohort. PLoS ONE 1:e89
doi: 10.1371/journal.pone.0000089
Heaton RK, Franklin DR, Ellis RJ, McCutchan JA, LLetendre SL, Leblanc S, Corkran SH, Duarte NA, Clifford DB, Woods SP, Collier CM, Marra S, Morgello MR, Mindt MJ, Taylor TD, Marcotte JH, Atkinson T, Wolfson BB, Gelman JC, McArthur DM, Simpson I, Abramson A, Gamst C, Fennema-Notestine TL, Jernigan J, Wong, I, Grant C, Group Group H (2011) "HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors." J Neurovirol 17(1):3-16
Heaton RK, Marcotte TD, Mindt MR, Sadek J, Moore DJ, Bentley H, McCutchan JA, Reicks C, Grant I, Group H (2004) "The impact of HIV-associated neuropsychological impairment on everyday functioning." J Int Neuropsychol Soc 10(3):317-331
Hunt PW, Deeks SG, Rodriguez B, Valdez H, Shade SB, Abrams DI, Kitahata MM, Krone M, Neilands TB, Brand RJ, Lederman MM, Martin JN (2003) Continued CD4 cell count increases in HIV-infected adults experiencing 4 years of viral suppression on antiretroviral therapy. AIDS 17(13):1907–1915
doi: 10.1097/00002030-200309050-00009
Hunt PW, Shulman NS, Hayes TL, Dahl V, Somsouk M, Funderburg NT, McLaughlin B, Landay AL, Adeyemi O, Gilman LE, Clagett B, Rodriguez B, Martin JN, Schacker TW, Shacklett BL, Palmer S, Lederman MM, Deeks SG (2013) "The immunologic effects of maraviroc intensification in treated HIV-infected individuals with incomplete CD4+ T-cell recovery: a randomized trial." Blood 121(23):4635–4646
Ickovics, JR, Hamburger ME, Vlahov D, Schoenbaum EE, Schuman P, Boland RJ, Moore J, Group H.I.V.E.R.S (2001) "Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research Study." JAMA 285(11):1466–1474
Kallianpur KJ, Walker M, Gerschenson M, Shikuma CM, Gangcuangco LMA, Kohorn L, Libutti DE, Nir TM, Jahanshad N, Thompson PM, Paul R (2020) Systemic mitochondrial oxidative phosphorylation protein levels correlate with neuroimaging measures in chronically hiv-infected individuals. AIDS Res Hum Retroviruses 36(1):83–91
doi: 10.1089/aid.2019.0240
Kaufmann GR, Perrin L, Pantaleo G, Opravil M, Furrer H, Telenti A, Hirschel B, Ledergerber B, Vernazza P, Bernasconi E, Rickenbach M, Egger M, Battegay M, Swiss HIVCSG (2003) CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study. Arch Intern Med 163(18):2187–2195
doi: 10.1001/archinte.163.18.2187
Lederman MM, Calabrese L, Funderburg NT, Clagett B, Medvik K, Bonilla H, Gripshover B, Salata RA, Taege A, Lisgaris M, McComsey GA, Kirchner E, Baum J, Shive C, Asaad R, Kalayjian RC, Sieg SF, Rodriguez B (2011) "Immunologic failure despite suppressive antiretroviral therapy is related to activation and turnover of memory CD4 cells." J Infect Dis 204(8):1217–1226
Lewden C, Chene G, Morlat P, Raffi F, Dupon M, Dellamonica P, Pellegrin JL, Katlama C, Dabis F, Leport C, Agence Nationale de Recherches sur le Sida et les Hepatites Virales COA-CSG, Agence Nationale de Recherches sur le Sida et les Hepatites Virales COASG (2007) "HIV-infected adults with a CD4 cell count greater than 500 cells/mm3 on long-term combination antiretroviral therapy reach same mortality rates as the general population." J Acquir Immune Defic Syndr 46(1):72–77
Luo Z, Li Z, Martin L, Wan Z, Meissner EG, Espinosa E, Wu H, Yu X, Fu P, Julia Westerink MA, Kilby JM, Wu J, Huang L, Heath SL, Li Z, Jiang W (2017) Pathological role of anti-CD4 antibodies in HIV-infected immunologic nonresponders receiving virus-suppressive antiretroviral therapy. J Infect Dis 216(1):82–91
doi: 10.1093/infdis/jix223
Maclean AG, Belenchia GE, Bieniemy DN, Moroney-Rasmussen TA, Lackner AA (2005) Simian immunodeficiency virus disrupts extended lengths of the blood–brain barrier. J Med Primatol 34(5–6):237–242
doi: 10.1111/j.1600-0684.2005.00121.x
Mader S, Brimberg L, Diamond B (2017) The role of brain-reactive autoantibodies in brain pathology and cognitive impairment. Front Immunol 8:1101
doi: 10.3389/fimmu.2017.01101
Mocroft A, Phillips AN, Gatell J, Ledergerber B, Fisher M, Clumeck N, Losso M, Lazzarin A, Fatkenheuer G, Lundgren JD (2007) Normalisation of CD4 counts in patients with HIV-1 infection and maximum virological suppression who are taking combination antiretroviral therapy: an observational cohort study. The Lancet 370(9585):407–413
doi: 10.1016/S0140-6736(07)60948-9
Moore RD, Keruly JC, Bartlett JG (2012) Improvement in the health of HIV-infected persons in care: reducing disparities. Clin Infect Dis 55(9):1242–1251
doi: 10.1093/cid/cis654
Okoye AA, Picker LJ (2013) CD4(+) T-cell depletion in HIV infection: mechanisms of immunological failure. Immunol Rev 254(1):54–64
doi: 10.1111/imr.12066
Pakker NG, Notermans DW, de Boer RJ, Roos MT, de Wolf F, Hill A, Leonard JM, Danner SA, Miedema F, Schellekens PT (1998) Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: a composite of redistribution and proliferation. Nat Med 4(2):208–214
doi: 10.1038/nm0298-208
Teixeira L, Valdez H, McCune JM, Koup RA, Badley AD, Hellerstein MK, Napolitano LA, Douek DC, Mbisa G, Deeks S, Harris JM, Barbour JD, Gross BH, Francis IR, Halvorsen R, Asaad R, Lederman MM (2001) Poor CD4 T cell restoration after suppression of HIV-1 replication may reflect lower thymic function. AIDS 15(14):1749–1756
doi: 10.1097/00002030-200109280-00002
Tozzi V, Balestra P, Salvatori MF, Vlassi C, Liuzzi G, Giancola ML, Giulianelli M, Narciso P, Antinori A (2009) Changes in cognition during antiretroviral therapy: comparison of 2 different ranking systems to measure antiretroviral drug efficacy on HIV-associated neurocognitive disorders. J Acquir Immune Defic Syndr 52(1):56–63
doi: 10.1097/QAI.0b013e3181af83d6
Weber R, Sabin CA, Friis-Moller N, Reiss P, El-Sadr WM, Kirk O, Dabis F, Law MG, Pradier C, De Wit S, Akerlund B, Calvo G, Monforte A, Rickenbach M, Ledergerber B, Phillips AN, Lundgren JD (2006) Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A: D study. Arch Intern Med 166(15):1632–1641
doi: 10.1001/archinte.166.15.1632
Wright EJ, Grund B, Robertson K, Brew BJ, Roediger M, Bain MP, Drummond F, Vjecha MJ, Hoy J, Miller C, Penalva de Oliveira AC, Pumpradit W, Shlay JC, El-Sadr W, Price RW, Group ISS (2010) "Cardiovascular risk factors associated with lower baseline cognitive performance in HIV-positive persons." Neurology 75(10):864-873
Wright PW, Pyakurel A, Vaida FF, Price RW, Lee E, Peterson J, Fuchs D, Zetterberg H, Robertson KR, Walter R, Meyerhoff DJ, Spudich SS, Ances BM (2016) Putamen volume and its clinical and neurological correlates in primary HIV infection. AIDS 30(11):1789–1794
doi: 10.1097/QAD.0000000000001103